Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-17T09:17:35.142Z Has data issue: false hasContentIssue false

48 - HHV-6A, 6B, and 7: immunobiology and host response

from Part III - Pathogenesis, clinical disease, host response, and epidemiology: HHV- 6A, 6B, and 7

Published online by Cambridge University Press:  24 December 2009

By
Fu-Zhang Wang  and
Philip E. Pellett
Edited by
Ann Arvin ,
Gabriella Campadelli-Fiume ,
Edward Mocarski ,
Patrick S. Moore ,
Bernard Roizman ,
Richard Whitley  and
Koichi Yamanishi
Fu-Zhang Wang
Affiliation:
Molecular Biology Department, Lerner Research Institute, Cleveland Clinic Foundation, OH, USA
Philip E. Pellett
Affiliation:
Molecular Biology Department, Lerner Research Institute, Cleveland Clinic Foundation, OH, USA
Ann Arvin
Affiliation:
Stanford University, California
Gabriella Campadelli-Fiume
Affiliation:
Università degli Studi, Bologna, Italy
Edward Mocarski
Affiliation:
Emory University, Atlanta
Patrick S. Moore
Affiliation:
University of Pittsburgh
Bernard Roizman
Affiliation:
University of Chicago
Richard Whitley
Affiliation:
University of Alabama, Birmingham
Koichi Yamanishi
Affiliation:
University of Osaka, Japan
Get access

Summary

Introduction

The discoveries of Human herpesvirus 6 variant A (HHV-6A), Human herpesvirus 6 variant B (HHV-6B) and Human herpesvirus 7 (HHV-7) followed the development of methods for activation and long-term culture of peripheral blood T lymphocytes. Based on their shared biological properties and nucleotide sequences, HHV-6A, HHV-6B, and HHV-7 are classified as members of the roseolovirus genus of the betaherpesvirus subfamily. HHV-6A and HHV-6B are very closely related, with most of their encoded proteins sharing greater than 90% amino acid sequence identity; most HHV-7 protein sequences share 30% to 60% amino acid sequence identity with their HHV-6 counterparts (for review, see Yamanishi et al., 2007 and elsewhere in this volume). Roseoloviruses share many genetic and biologic properties with the more distantly related cytomegaloviruses. All of the roseoloviruses infect T lymphocytes in vivo and in vitro, cause similar damage to infected cells, and have overlapping but distinct disease spectra.

Primary infection with HHV-6B is the major cause of roseola infantum (also known as roseola, exanthem subitum, 3-day-fever, or sixth disease), a febrile rash illness common in early childhood (for review, see Braun et al., 1997; Yamanishi et al., 2007 and elsewhere in this volume); primary HHV-7 infections can also cause roseola, albeit less frequently. Roseoloviruses can affect the central nervous system; patients with HHV-6 primary infection sometimes develop seizures or convulsions.

Type
Chapter
Information
Human Herpesviruses
Biology, Therapy, and Immunoprophylaxis
 , pp. 850 - 874
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ablashi, D. V., Balachandran, N., Josephs, S. F.et al. (1991). Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology, 184, 545–552.CrossRefGoogle ScholarPubMed
Ablashi, D. V., Lapps, W., Kaplan, M., Whitman, J. E., Richert, J. R., and Pearson, G. R. (1998). Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler., 4(6), 490–496.CrossRefGoogle ScholarPubMed
Ablashi, D. V., Eastman, H. B., Owen, C. B.et al. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol., 16(3), 179–191.CrossRefGoogle ScholarPubMed
Adler, S. P., McVoy, M., Chou, S., Hempfling, S., Yamanishi, K., and Britt, W. (1993). Antibodies induced by a primary cytomegalovirus infection react with human herpesvirus 6 proteins. J. Infect. Dis., 168, 1119–1126.CrossRefGoogle ScholarPubMed
Anderson, R. A. and Gompels, U. A. (1999). N- and C-terminal external domains of human herpesvirus-6 glycoprotein H affect a fusion-associated conformation mediated by glycoprotein L binding the N terminus. J. Gen. Virol., 80, 1485–1494.CrossRefGoogle ScholarPubMed
Anderson, R. A., Liu, D. X., and Gompels, U. A. (1996). Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology, 217(2), 517–526.CrossRefGoogle ScholarPubMed
Arena, A., Liberto, M. C., Capozza, A. B., and Foca, A. (1997). Productive HHV-6 infection in differentiated U937 cells: role of TNF alpha in regulation of HHV-6. New Microbiol., 20(1), 13–20.Google ScholarPubMed
Arena, A., Liberto, M. C., Iannello, D., Capozza, A. B., and Foca, A. (1999). Altered cytokine production after human herpes virus type 6 infection. N. Microbiol., 22(4), 293–300.Google ScholarPubMed
Arena, A., Merendino, R. A., Bonina, L., Iannello, D., Stassi, G., and Mastroeni, P. (2000). Role of IL-15 on monocytic resistance to human herpesvirus 6 infection. N. Microbiol., 23(2), 105–112.Google ScholarPubMed
Arsenault, S., Gravel, A., Gosselin, J., and Flamand, L. (2003). Generation and characterization of a monoclonal antibody specific for human herpesvirus 6 variant A immediate-early 2 protein. J. Clin. Virol., 28(3), 284–290.CrossRefGoogle ScholarPubMed
Arvin, A., Sharp, M., Smith, S., et al. (1991). Equivalent recognition of varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol., 146, 257–264.Google ScholarPubMed
Asada, H., Yalcin, S., Balachandra, K., Higashi, K., and Yamanishi, K. (1989). Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus. J. Clin. Microbiol., 27, 2204–2207.Google ScholarPubMed
Asada, H., Klaus-Kovtun, V., Golding, H., Katz, S. I., and Blauvelt, A. (1999). Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J. Virol., 73(5), 4019–4028.Google ScholarPubMed
Atedzoe, B. N., Ahmad, A., and Menezes, J. (1997). Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol., 159(10), 4966–4972.Google ScholarPubMed
Balachandra, K., Ayuthaya, P. I., Auwanit, W.et al. (1989). Prevalence of antibody to human herpesvirus 6 in women and children. Microbiol. Immunol., 33(6), 515–518.CrossRefGoogle ScholarPubMed
Balachandra, N., Amelse, R. E., Zhou, W. W., and Chang, C. K. (1989). Identification of proteins specific for human herpesvirus 6-infected human T cells. J. Virol., 63, 2835–2840.Google Scholar
Berneman, Z. N., Ablashi, D. V., Li, G.et al. (1992). Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc. Natl Acad. Sci. USA, 89(21), 10552–10556.CrossRefGoogle ScholarPubMed
Black, J. B. and Pellett, P. E. (1999). Human herpesvirus 7. Rev. Med. Virol., 9, 245–262.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Black, J. B., Sanderlin, K. C., Goldsmith, C. S., Gary, H. E., Lopez, C., and Pellett, P. E. (1989). Growth properties of human herpesvirus-6 strain Z29. J. Virol. Methods, 26, 133–145.CrossRefGoogle ScholarPubMed
Black, J. B., Lopez, C., and Pellett, P. E. (1992). Induction of host cell protein synthesis by human herpesvirus 6. Virus Res., 22(1), 13–23.CrossRefGoogle ScholarPubMed
Black, J. B., Durigon, E., Kite-Powell, K.et al. (1996a). Seroconversion to human herpesvirus 6 and human herpesvirus 7 among Brazilian children with clinical diagnoses of measles or rubella. Clin. Infect. Dis., 23, 1156–1158.CrossRefGoogle Scholar
Black, J. B., Schwarz, T. F., Patton, J. L.et al. (1996b). Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin. Diagn. Lab. Immunol., 3, 79–83.Google Scholar
Boeckh, M. and Nichols, W. S. (2003). Immunosuppressive effects of beta-herpesviruses. Herpes, 10(1), 12–16.Google ScholarPubMed
Boutolleau, D., Fernandez, C., Andre, E.et al. (2003). Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis., 187(2), 179–186.CrossRefGoogle ScholarPubMed
Braun, D. K., Dominguez, G., and Pellett, P. E. (1997). Human herpesvirus 6. Clin. Microbiol. Rev., 10, 521–567.Google ScholarPubMed
Burd, E. M. and Carrigan, D. R. (1993). Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res., 29, 79–90.CrossRefGoogle ScholarPubMed
Burd, E. M., Knox, K. K., and Carrigan D. R. (1993). Human herpesvirus-6-associated suppression of growth factor-induced macrophage maturation in human bone marrow cultures. Blood, 81, 1645–1650.Google ScholarPubMed
Campadelli-Fiume, G., Guerrini, S., Liu, X., and Foa-Tomasi, L. (1993). Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants A and B. J. Gen. Virol., 74, 2257–2262.CrossRefGoogle ScholarPubMed
Carricart, S. E., Bustos, D., Biganzoli, P., Nates, S. E., and Pavan, J. V. (2004). Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J. Clin. Virol., 31(4), 266–269.Google ScholarPubMed
Carrigan, D. R. (1995). Human herpesvirus-6 and bone marrow transplantation. Blood, 85(1), 294–295.Google ScholarPubMed
Caruso, A., Rotola, A., Comar, M.et al. (2002). HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J. Med. Virol., 67(4), 528–533.CrossRefGoogle ScholarPubMed
Caruso, A., Favilli, F., Rotola, A.et al. (2003). Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J. Med. Virol., 70(3), 451–458.CrossRefGoogle ScholarPubMed
Caselli, E., Boni, M., Bracci, A.et al. (2002). Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J. Clin. Microbiol., 40(11), 4131–4137.CrossRefGoogle ScholarPubMed
Caserta, M. T., Hall, C. B., Schnabel, K., Long, C. E., and D'Heron, N. (1998). Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J. Pediatr., 133(3), 386–389.CrossRefGoogle ScholarPubMed
Caserta, M. T., Mock, D. J., and Dewhurst, S. (2001). Human herpesvirus 6. Clin. Infect. Dis., 33(6), 829–833.CrossRefGoogle ScholarPubMed
Cermelli, C., Concari, M., Carubbi, F.et al. (1996). Growth of human herpesvirus 6 in HEPG2 cells. Virus Res., 45, 75–85.CrossRefGoogle ScholarPubMed
Cermelli, C., Berti, R., Soldan, S. S. (2003). et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J. Infect. Dis., 187(9), 1377–1387.CrossRefGoogle ScholarPubMed
Cesarman, E. and Knowles, D. M. (1999). The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin. Cancer. Biol., 9(3), 165–174.CrossRefGoogle Scholar
Chandran, B., Tirawatnapong, S., Pfeiffer, B. and Ablashi, D. V. (1992). Antigenic relationships among human herpesvirus-6 isolates. J. Med. Virol., 37(4), 247–254.CrossRefGoogle ScholarPubMed
Chapenko, S., Millers, A., Nora, Z., Logina, I., Kukaine, R., and Murovska, M. (2003). Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol., 69(1), 111–117.CrossRefGoogle ScholarPubMed
Cirone, M., Campadelli-Fiume, G., Foa-Tomasi, L., Torrisi, M. R., and Faggioni, A. (1994). Human herpesvirus 6 envelope glycoproteins B and H-L complex are undetectable on the plasma membrane of infected lymphocytes. AIDSRes. Hum. Retroviruses, 10(2), 175–179.CrossRefGoogle Scholar
Cirone, M., Cuomo, L., Zompetta, C.et al. (2002). Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. J. Med. Virol., 68(2), 268–272.CrossRefGoogle ScholarPubMed
Clark, D. A. (2000). Human herpesvirus 6. Rev. Med. Virol., 10(3), 155–173.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Clark, D. A., and Griffiths, P. D. (2003). Human herpesvirus 6: relevance of infection in the immunocompromised host. Br. J. Haematol., 120(3), 384–395.CrossRefGoogle ScholarPubMed
Clark, D. A., Ait-Khaled, M., Wheeler, A. C.et al. (1996). Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J. Gen. Virol., 77, 2271–2275.CrossRefGoogle ScholarPubMed
Cone, R. W., Huang, M. L., Hackman, R. C., and Corey, L. (1996). Coinfection with human herpesvirus 6 variants A and B in lung tissue. J. Clin. Microbiol., 34, 877–881.Google Scholar
Dahl, H., Fjaertoft, G., Norsted, T., Wang, F. Z., Mousavi-Jazi, M., and Linde, A. (1999). Reactivation of human herpesvirus 6 during pregnancy. J. Infect. Dis., 180(6), 2035–2038.CrossRefGoogle ScholarPubMed
DesJardin, J. A., Gibbons, L., Cho, E.et al. (1998). Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J. Infect. Dis., 178(6), 1783–1786.CrossRefGoogle ScholarPubMed
DesJardin, J. A., Cho, E., Supran, S., Gibbons, L., Werner, B. G., and Snydman, D. R. (2001). Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin. Infect. Dis., 33(8), 1358–1362.CrossRefGoogle ScholarPubMed
Dewin, D. R., Catusse, J., and Gompels, U. A. (2000). Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform. J. Immunol., 176(1), 544–556.CrossRefGoogle Scholar
Dhepakson, P., Mori, Y., Jiang, Y. B.et al. (2002). Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol., 83(4), 847–854.CrossRefGoogle ScholarPubMed
Dockrell, D. H., Mendez, J. C., Jones, M.et al. (1999). Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation, 67(3), 399–403.CrossRefGoogle ScholarPubMed
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol., 73, 8040–8052.Google ScholarPubMed
Eizuru, Y. and Minamishima, Y. (1992). Evidence for putative immediate early antigens in human herpesvirus 6-infected cells. J. Gen. Virol., 73, 2161–2165.CrossRefGoogle ScholarPubMed
Emery, V. C., Atkins, M. C., Bowen, E. F.et al. (1999). Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J. Med. Virol., 57(3), 278–282.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Enbom, M., Martin, C., Fredrikson, S., Jagdahl, L., Dahl, H., and Linde, A. (1997). Intrathecal antibody production to lymphotropic herpesviruses in patients with multiple sclerosis. Neurol. Infect. Epidemiol., 2, 107–111.Google Scholar
Enbom, M., Wang, F. Z., Fredrickson, S., Martin, C., Dahl, H., and Linde, A. (1999). Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin. Diagn. Lab. Immunol., 6, 545–549.Google ScholarPubMed
Feldstein, A. E., Razonable, R. R., Boyce, T. G.et al. (2003). Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr. Transpl., 7(2), 125–129.CrossRefGoogle ScholarPubMed
Flamand, L., Gosselin, J., D'Addario, M.et al. (1991). Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J. Virol., 65(9), 5105–5110.Google Scholar
Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D., and Menezes, J. (1995). Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation [published erratum appears in Blood, 86, 418, 1995]. Blood, 85(5), 1263–1271.Google Scholar
Flamand, L., Stefanescu, I., and Menezes, J. (1996). Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest., 97, 1373–1381.CrossRefGoogle ScholarPubMed
Flamand, L., Romerio, F., Reitz, M. S., and Gallo, R. C. (1998). CD4 promoter transactivation by human herpesvirus 6. J. Virol., 72(11), 8797–8805.Google ScholarPubMed
Flebbe-Rehwaldt, L. M., Wood, C., and Chandran, B. (2000). Characterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J. Virol., 74(23), 11040–11054.CrossRefGoogle Scholar
Foa-Tomasi, L., Boscaro, A., Gaeta, S., and Campadelli-Fiume, G. (1991). Monoclonal antibodies to gp100 inhibit penetration of human herpesvirus 6 and polykaryocyte formation in susceptible cells. J. Virol., 65, 4124–4129.Google ScholarPubMed
Foa-Tomasi, L., Guerrini, S., Huang, T., and Campadelli-Fiume, G. (1992). Characterization of human herpesvirus-6 (U1102) and (GS) gp112 and identification of the Z29-specified homolog. Virology, 191, 511–516.CrossRefGoogle ScholarPubMed
Foa-Tomasi, L., Avitabile, E., Ke, L., and Campadelli-Fiume, G. (1994). Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross-reactivity with human herpesvirus 6. J. Gen. Virol., 75, 2719–2727.CrossRefGoogle ScholarPubMed
Foa-Tomasi, L., Fiorilli, M. P., Avitabile, E., and Campadelli-Fiume, G. (1996). Identification of an 85 kDa phosphoprotein as an immunodominant protein specific for human herpesvirus 7-infected cells. J. Gen. Virol., 77, 511–518.CrossRefGoogle ScholarPubMed
Fox, J. D., Briggs, M., Ward, P. A., and Tedder, R. S. (1990). Human herpesvirus 6 in salivary glands. Lancet, 336(8715), 590–593.CrossRefGoogle ScholarPubMed
Franti, M., Aubin, J. T., Saint-Maur, G.et al. (2002). Immune reactivity of human sera to the glycoprotein B of human herpesvirus 7. J. Clin. Microbiol., 40(1), 44–51.CrossRefGoogle ScholarPubMed
Frenkel, N., Schirmer, E. C., Katsafanas, G., and June, C. H. (1990). T-cell activation is required for efficient replication of human herpesvirus 6. J. Virol., 64(9), 4598–4602.Google ScholarPubMed
Furukawa, M., Yasukawa, M., Yakushijin, Y., and Fujita S. (1994). Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells. J. Immunol., 152, 5768–5775.Google ScholarPubMed
Gobbi, A., Stoddart, C. A., Malnati, M. S.et al. (1999). Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J. Exp. Med., 189(12), 1953–1960.CrossRefGoogle ScholarPubMed
Goodman, A. D., Mock, D. J., Powers, J. M., Baker, J. V., and Blumberg, B. M. (2003). Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J. Infect. Dis., 187(9), 1365–1376.CrossRefGoogle ScholarPubMed
Griffiths, P. D. (2003). The indirect effects of virus infections. Rev. Med. Virol., 13, 1–3.CrossRefGoogle ScholarPubMed
Griffiths, P. D., Ait-Khaled, M., Bearcroft, C. P.et al. (1999). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J. Med. Virol., 59(4), 496–501.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Grivel, J. C., Ito, Y., Faga, G.et al. (2001). Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat. Med., 7(11), 1232–1235.CrossRefGoogle Scholar
Grivel, J. C., Santoro, F., Chen, S.et al. (2003). Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol., 77(15), 8280–8289.CrossRefGoogle ScholarPubMed
Hall, C. B., Long, C. E., Schnabel, K. C.et al. (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med., 331(7), 432–438.CrossRefGoogle ScholarPubMed
Harma, M., Hockerstedt, K., and Lautenschlager, I. (2003). Human herpesvirus-6 and acute liver failure. Transplantation, 76(3), 536–539.Google ScholarPubMed
Hasegawa, A., Yasukawa, M., Sakai, I., and Fujita, S. (2001). Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J. Immunol., 166(2), 1125–1131.CrossRefGoogle ScholarPubMed
He, J., McCarthy, M., Zhou, Y., Chandran, B., and Wood, C. (1996). Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol., 70, 1296–1300.Google ScholarPubMed
Hidaka, Y., Okada, K., Kusuhara, K., Miyazaki, C., Tokugawa, K., and Ueda, K. (1994). Exanthem subitum and human herpesvirus 7 infection. Pediatr. Infect. Dis. J., 13(11), 1010–1011.Google ScholarPubMed
Hirata, Y., Kondo, K., and Yamanishi, K. (2001). Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J. Med. Virol., 65(3), 576–583.CrossRefGoogle Scholar
Horvat, R. T., Parmely, M. J., and Chandran, B. (1993). Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J. Infect. Dis., 167(6), 1274–1280.CrossRefGoogle ScholarPubMed
Huang, L. M., Lee, C. Y., Liu, M. Y., and Lee, P. I. (1997). Primary infections of human herpesvirus-7 and human herpesvirus-6: a comparative, longitudinal study up to 6 years of age. Acta Paediatr., 86, 604–608.CrossRefGoogle Scholar
Hudson, A. W., Howley, P. M., and Ploegh, H. L. (2001). A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol., 75(24), 12347–12358.CrossRefGoogle Scholar
Hudson, A. W., Blom, D., Howley, P. M., and Ploegh, H. L. (2003). The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic, 4(12), 824–837.CrossRefGoogle ScholarPubMed
Humar, A., Malkan, G., Moussa, G., Greig, P., Levy, G., and Mazzulli, T. (2000). Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J. Infect. Dis., 181(4), 1450–1453.CrossRefGoogle ScholarPubMed
Humar, A., Kumar, D., Caliendo, A. M.et al. (2002). Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation, 73(4), 599–604.CrossRefGoogle ScholarPubMed
Ichimi, R., Jin-no, T., and Ito, M. (1999). Induction of apoptosis in cord blood lymphocytes by HHV-6. J. Med. Virol., 58(1), 63–68.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
Inoue, Y., Yasukawa, M., and Fujita, S. (1997). Induction of T-cell apoptosis by human herpesvirus 6. J. Virol., 71, 3751–3759.Google ScholarPubMed
Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 72(7), 6104–6112.Google ScholarPubMed
Isomura, H., Yamada, M., Yoshida, M.et al. (1997). Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J. Med. Virol., 52(4), 406–412.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Isomura, H., Yoshida, M., Namba, H., and Yamada, M. (2003). Interaction of human herpesvirus 6 with human CD34 positive cells. J. Med. Virol., 70(3), 444–450.CrossRefGoogle ScholarPubMed
Iyengar, S., Levine, P. H., Ablashi, D., Neequaye, J., and Pearson, G. R. (1991). Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int. J. Cancer, 49, 551–557.CrossRefGoogle ScholarPubMed
Jacobs, F., Knoop, C., Brancart, F.et al. (2003). Human herpesvirus-6 infection after lung and heart–lung transplantation: a prospective longitudinal study. Transplantation, 75(12), 1996–2001.CrossRefGoogle ScholarPubMed
Kakimoto, M., Hasegawa, A., Fujita, S., and Yasukawa, M. (2002). Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol., 76(20), 10338–10345.CrossRefGoogle ScholarPubMed
Kano, Y., Inaoka, M., and Shiohara, T. (2004). Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol., 140(2), 183–188.CrossRefGoogle ScholarPubMed
Kempf, W., Adams, V., Wey, N.et al. (1997). CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc. Natl Acad. Sci. USA, 94, 7600–7605.CrossRefGoogle ScholarPubMed
Kempf, W., Adams, V., Mirandola, P.et al. (1998). Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J. Infect. Dis., 178(3), 841–845.CrossRefGoogle ScholarPubMed
Kidd, I. M., Clark, D. A., Sabin, C. A.et al. (2000). Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation, 69(11), 2400–2404.CrossRefGoogle ScholarPubMed
Kikuta, H., Lu, H., Tomizawa, K., and Matsumoto, S. (1990a). Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3. J. Infect. Dis., 161(6), 1085–1087.CrossRefGoogle Scholar
Kikuta, H., Nakane, A., Lu, H., Taguchi, Y., Minagawa, T., and Matsumoto, S. (1990b). Interferon induction by human herpesvirus 6 in human mononuclear cells. J. Infect. Dis., 162(1), 35–38.CrossRefGoogle Scholar
Knox, K. K., and Carrigan, D. R. (1992). In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J. Infect. Dis., 165(5), 925–929.CrossRefGoogle ScholarPubMed
Kondo, K., Kondo, T., Okuno, T., Takahashi, M., and Yamanishi, K. (1991). Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol., 72, 1401–1408.CrossRefGoogle ScholarPubMed
Kondo, K., Xu, J., and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl Acad. Sci. USA, 93(20), 11137–11142.CrossRefGoogle ScholarPubMed
Kondo, K., Kondo., T., Shimada, K., Amo, K., Miyagawa, H., and Yamanishi, K. (2002a). Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J. Med. Virol., 67(3), 364–369.CrossRefGoogle Scholar
Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., and Yamanishi, K. (2002b). Identification of human herpesvirus 6 latency-associated transcripts. J. Virol., 76(8), 4145–4151.CrossRefGoogle Scholar
Kong, H., Baerbig, Q., Duncan, L., Shepel, N., and Mayne, M. (2003). Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J. Neurovirol., 9(5), 539–550.CrossRefGoogle ScholarPubMed
Kositanont, U., Wasi, C., Wanprapar, N.et al. (1999). Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficicncy virus type 1. J. Infect. Dis., 180, 50–55.CrossRefGoogle ScholarPubMed
Kumagai, T., Yoshikawa, T., Yoshida, M.et al. (2006). Time course characteristics of human herpesvirus 6 specific cellular immune response and natural killer cell activity in patients with exanthema subitum. J. Med. Virol., 78(6), 792–799.CrossRefGoogle ScholarPubMed
LaCroix, S., Stewart, J. A., Thouless, M. E., and Black, J. B. (2000). An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6. Clin. Diagn. Lab. Immunol., 7(5), 823–827.Google ScholarPubMed
Landini, M. P., Lazzarotto, T., Xu, J., Geballe, A. P., and Mocarski, E. S. (2000). Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol. Blood Marrow Transpl., 6(2), 100–108.CrossRefGoogle ScholarPubMed
Lautenschlager, I., Harma, M., Hockerstedt, K., Linnavuori, K., Loginov, R., and Taskinen, E. (2002). Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J. Hepatol., 37(5), 648–654.CrossRefGoogle ScholarPubMed
Li, C., Goodrich, J. M., and Yang, X. (1997). Interferon-gamma (IFN-gamma) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage. Clin. Exp. Immunol., 109(3), 421–425.CrossRefGoogle ScholarPubMed
Linde, A., Dahl, H., Wahren, B., Fridell, E., Salahuddin, Z., and Biberfeld, P. (1988). IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein–Barr virus infections and cytomegalovirus infections. J. Virol. Methods, 21, 117–123.CrossRefGoogle ScholarPubMed
Littler, E., Lawrence, G., Liu, M. Y., Barrell, B. G., and Arrand, J. R. (1990). Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J. Virol., 64, 714–722.Google ScholarPubMed
Liu, D. X., Gompels, U. A., Foa-Tomasi, L., and Campadelli-Fiume, G. (1993a). Human herpesvirus-6 glycoprotein H and L homologs are components of the GP100 complex and the GH external domain is the target for neutralizing monoclonal antibodies. Virology, 197, 12–22.CrossRefGoogle Scholar
Liu, D. X., Gompels, U. A., Nicholas, J., and Lelliott, C. (1993b). Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein. J. Gen. Virol., 74, 1847–1857.CrossRefGoogle Scholar
Ljungman, P. (2002). Beta-herpesvirus challenges in the transplant recipient. J. Infect. Dis., 186 Suppl. 1, S99–S109.CrossRefGoogle ScholarPubMed
Ljungman, P., Wahren, B., and Sundqvist, V. A. (1985). Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J. Virol. Method., 12, 199–208.CrossRefGoogle ScholarPubMed
Lowance, D., Neumayer, H. H., Legendre, C. M.et al. (1999). Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N. Engl. J. Med., 340(19), 1462–1470.CrossRefGoogle ScholarPubMed
Luppi, M., Barozzi, P., Morris, C., et al. (1999). Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J. Virol., 73(1), 754–759.Google ScholarPubMed
Lusso, P., Maria, A., Malnati, M.et al. (1991a). Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature, 349(6309), 533–535.CrossRefGoogle Scholar
Lusso, P., Malnati, M., Maria, A.et al. (1991b). Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J. Immunol., 147, 685–691.Google Scholar
Lusso, P., Malnati, M. S., Garzino-Demo, A., Crowley, R. W., Long, E. O., and Gallo, R. C. (1993). Infection of natural killer cells by human herpesvirus 6. Nature, 362(6419), 458–462.CrossRefGoogle ScholarPubMed
Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berneman, Z. N., and Gallo, R. C. (1994). CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc. Natl Acad. Sci. USA, 91, 3872–3876.CrossRefGoogle ScholarPubMed
Lusso, P., Garzino-Demo, A., Crowley, R. W., and Malnati, M. S. (1995). Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J. Exp. Med., 181(4), 1303–1310.CrossRefGoogle ScholarPubMed
Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Gerstoft, J., and Schwartz, T. W. (2003). A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem., 278(13), 10928–10933.CrossRefGoogle ScholarPubMed
Malnati, M. S., Lusso, P., Ciccone, E., Moretta, A., Moretta, L., and Long, E. O. (1993). Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med., 178(3), 961–969.CrossRefGoogle ScholarPubMed
Mayne, M., Cheadle, C., Soldan, S. S.et al. (2001). Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol., 75(23), 11641–11650.CrossRefGoogle ScholarPubMed
Meeuwsen, S., Persoon-Deen, C., Bsibsi, M.et al. (2005). Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A. J. Neuroimmunol., 164(1–2), 37–47.CrossRefGoogle ScholarPubMed
Milne, R. S., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A., and Gompels, U. A. (2000). RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J. Immunol., 164(5), 2396–2404.CrossRefGoogle ScholarPubMed
Mirandola, P., Secchiero, P., Pierpaoli, S.et al. (2000). Infection of CD34(+) hematopoietic progenitor cells by human herpesvirus 7 (HHV-7). Blood, 96(1), 126–131.Google Scholar
Miyoshi, H., Tanaka-Taya, K., Hara, J.et al. (2001). Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation. Bone Marrow Transpl., 27(10), 1065–1070.CrossRefGoogle ScholarPubMed
Molden, J., Chang, Y., You, Y., Moore, P. S., and Goldsmith, M. A. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem., 272(31), 19625–19631.CrossRefGoogle ScholarPubMed
Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P., and Yamanishi, K. (2002). Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J. Virol., 76(13), 6750–6761.CrossRefGoogle ScholarPubMed
Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003a). The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J. Virol., 77(4), 2452–2458.CrossRefGoogle Scholar
Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., and Yamanishi, K. (2003b). Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J. Virol., 77(8), 4992–4999.CrossRefGoogle Scholar
Nakagawa, N., Mukai, T., Sakamoto, J.et al. (1997). Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7. J. Gen. Virol., 78, 1131–1137.CrossRefGoogle ScholarPubMed
Nakano, K., Tadagaki, K., Isegawa, Y., Aye, M. M., Zou, P., and Yamanishi, K. (2003). Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 77(14), 8108–8115.CrossRefGoogle ScholarPubMed
Neipel, F., Ellinger, K., and Fleckenstein, B. (1992). Gene for the major antigenic structural protein (p100) of human herpesvirus 6. J. Virol., 66, 3918–3924.Google ScholarPubMed
Ohashi, M., Yoshikawa, T., Ihira, M.et al. (2002). Reactivation of human herpesvirus 6 and 7 in pregnant women. J. Med. Virol., 67(3), 354–358.CrossRefGoogle ScholarPubMed
Okuno, T., Sao, H., Asada, H., Shiraki, K., Takahashi, M., and Yamanishi, K. (1990). Analysis of a glycoprotein for human herpesvirus 6 (HHV-6) using monoclonal antibodies. Virology, 176, 625–628.CrossRefGoogle ScholarPubMed
Okuno, T., Shao, H., Asada, H., Shiraki, K., Takahashi, M., and Yamanishi, K. (1992). Analysis of human herpesvirus 6 glycoproteins recognized by monoclonal antibody OHV1. J. Gen. Virol., 73, 443–447.CrossRefGoogle ScholarPubMed
Oliveira, S. A., Turner, D. J., Knowles, W., Nascimento, J. P., Brown, D. W., and Ward, K. N. (2003). Primary human herpesvirus-6 and -7 infections, often coinciding, misdiagnosed as measles in children from a tropical region of Brazil. Epidemiol. Infect., 131(2), 873–879.CrossRefGoogle ScholarPubMed
Osman, H. K. E., Peiris, J. S. M., Taylor, C. E., Warwicker, P., Jarrett, R. F., and Madeley, C. R. (1996). “Cytomegalovirus disease” in renal allograft recipients: is human herpesvirus 7 a cofactor for disease progression?J. Med. Virol., 48, 295–301.3.0.CO;2-2>CrossRefGoogle Scholar
Øster, B., Bundgaard, B., and Hollsberg, P. (2005). Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J. Virol., 79(3), 1961–1965.CrossRefGoogle Scholar
Patnaik, M., Komaroff, A. L., Conley, E., Ojo-Amaize, E. A., and Peter, J. B. (1995). Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J. Infect. Dis., 172, 1264–1267.CrossRefGoogle ScholarPubMed
Pellett, P. E., Sanchez-Martinez, D., Dominguez, G.et al. (1993). A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: identification and characterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope. Virology, 195(2), 521–531.CrossRefGoogle ScholarPubMed
Qian, G., Wood, C., and Chandran, B. (1993). Identification and characterization of glycoprotein gH of human herpesvirus-6. Virology, 194(1), 380–386.CrossRefGoogle ScholarPubMed
Rapp, J. C., Krug, L. T., Inoue, N., Dambaugh, T. R., and Pellett, P. E. (2000). U94, the human herpesvirus 6 homolog of the parvovirus nonstructural gene, is highly conserved among isolates and is expressed at low mRNA levels as a spliced transcript. Virology, 268, 504–516.CrossRefGoogle ScholarPubMed
Razvi, E. S. and Welsh, R. M. (1995). Apoptosis in viral infections. Adv. Virus Res. 45, 1–60.CrossRefGoogle ScholarPubMed
Robert, C., Aubin, J. T., Visse, B., Fillet, A. M., Huraux, J. M., and Agut, H. (1996). Difference in permissiveness of human fibroblast cells to variants A and B of human herpesvirus-6. Res. Virol., 147(4), 219–225.CrossRefGoogle Scholar
Roffman, E. and Frenkel, N. (1990). Interleukin-2 inhibits the replication of human herpesvirus-6 in mature thymocytes. Virology, 175(2), 591–594.CrossRefGoogle ScholarPubMed
Roffman, E. and Frenkel, N. (1991). Replication of human herpesvirus-6 in thymocytes activated by anti-CD3 antibody. J. Infect. Dis., 164, 617–618.CrossRefGoogle ScholarPubMed
Rogers, J., Rohal, S., Carrigan, D. R.et al. (2000). Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation, 69(12), 2566–2573.CrossRefGoogle ScholarPubMed
Rossi, C., Delforge, M. L., Jacobs, F.et al. (2001). Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation, 71(2), 288–292.CrossRefGoogle Scholar
Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., and Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl Acad. Sci. USA, 95(23), 13911–13916.CrossRefGoogle ScholarPubMed
Roush, K. S., Domiati-Saad, R. K., Margraf, L. R.et al. (2001). Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am. J. Clin. Pathol., 116(5), 648–654.CrossRefGoogle ScholarPubMed
Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., and Lusso, P. (1999). CD46 is a cellular receptor from human herpesvirus 6. Cell, 99, 817–827.CrossRefGoogle ScholarPubMed
Santoro, F., Greenstone, H. L., Insinga, A.et al. (2003). Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem., 278(28), 25964–25969.CrossRefGoogle ScholarPubMed
Secchiero, P., Flamand, L., Gilbellini, D.et al. (1997). Human herpesvirus 7 induces CD4+ T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood, 90, 4502–4512.Google ScholarPubMed
Secchiero, P., Bertolaso, L., Casareto, L.et al. (1998a). Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood, 92(5), 1685–1696.Google Scholar
Secchiero, P., Bertolaso, L., Gibellini, D.et al. (1998b). Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. Eur. J. Immunol., 28(5), 1587–1596.3.0.CO;2-#>CrossRefGoogle Scholar
Secchiero, P., Zella, D., Barabitskaja, O.et al. (1998c). Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. Blood, 92(12), 4521–4528.Google Scholar
Secchiero, P., Mirandola, P., Zella, D.et al. (2001). Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells. Blood, 98(8), 2474–2481.CrossRefGoogle ScholarPubMed
Shiraki, K., Okuno, T., Yamanishi, K., and Takahashi, M. (1989). Virion and nonstructural polypeptides of human herpesvirus-6. Virus. Res., 13, 173–178.CrossRefGoogle ScholarPubMed
Simmons, A., Demmrich, Y., La Vista, A., and Smith, K. (1992). Replication of human herpesvirus 6 in epithelial cells in vitro. J. Infect. Dis., 166(1), 202–205.CrossRefGoogle ScholarPubMed
Singh, N., Bentlejewski, C., Carrigan, D. R., Gayowski, T., Knox, K. K., and Zeevi, A. (2002a). Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients. Transpl. Infect. Dis., 4(2), 59–63.CrossRefGoogle Scholar
Singh, N., Husain, S., Carrigan, D. R.et al. (2002b). Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin. Transpl., 16(2), 92–96.CrossRefGoogle Scholar
Skrinkosky, D., Hocknell, P., Whetter, L., Secchiero, P., Chandran, B., and Dewhurst, S. (2000). Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7. J. Virol., 74, 4530–4540.CrossRefGoogle Scholar
Skrincosky, D., Willis, R. A., Hocknell, P. K.et al. (2001). Epitope mapping of human herpesvirus-7 gp65 using monoclonal antibodies. Arch. Virol., 146(9), 1705–1722.CrossRefGoogle ScholarPubMed
Smith, A., Santoro, F., Lullo, G., Dagna, L., Verani, A., and Lusso, P. (2003), Selective suppression of IL-12 production by human herpesvirus 6. Blood, 102(8), 2877–2884.CrossRefGoogle ScholarPubMed
Soldan, S. S., Berti, R., Salem, N.et al. (1997), Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med., 3(12), 1394–1397.CrossRefGoogle ScholarPubMed
Soldan, S. S., Leist, T. P., Juhng, K. N., McFarland, H. F. and Jacobson, S. (2000). Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann. Neurol., 47(3), 306–313.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Stefan, A., Lillo, M., Frascaroli, G., Secchiero, P., Neipel, F., and Campadelli-Fiume, G. (1999). Development of recombinant diagnostic reagents based on pp85(U14) and p86(U11) proteins to detect the human immune response to human herpesvirus 7 infection. J. Clin. Microbiol., 37, 3980–3985.Google ScholarPubMed
Suga, S., Yoshikawa, T., Asano, Y., Yazaki, T., and Ozaki, T. (1990). Neutralizing antibody assay for human herpesvirus-6. J. Med. Virol., 30(1), 14–19.CrossRefGoogle ScholarPubMed
Suga, S., Yoshikawa, T., Asano, Y.et al. (1992a). IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol. Immunol., 36(5), 495–506.CrossRefGoogle Scholar
Suga, S., Yoshikawa, T., Asano, Y., Nakashima, T., Kobayashi, I., and Yazaki, T. (1992b). Activation of human herpesvirus-6 in children with acute measles. J. Med. Virol., 38, 278–282.CrossRefGoogle Scholar
Takahashi, K., Sonoda, S., Higashi, K.et al. (1989). Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol., 63, 3161–3163.Google ScholarPubMed
Takaku, T., Ohyashiki, J. H., Zhang, Y., and Ohyashiki, K. (2005). Estimating immunoregulatory gene networks in human herpesvirus type 6-infected T cells. Biochem. Biophys. Res. Commun., 336(2), 469–477.CrossRefGoogle ScholarPubMed
Takahashi, K., Segal, E., Kondo, T.et al. (1992). Interferon and natural killer cell activity in patients with exanthem subitum. Pediatr. Infect. Dis. J., 11(5), 369–373.CrossRefGoogle ScholarPubMed
Takeda, K., Okuno, T., Isegawa, Y., and Yamanishi, K. (1996). Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6). Virology, 222, 176–183.CrossRefGoogle Scholar
Takeda, K., Haque, M., Sunagawa, T., Okuno, T., Isegawa, Y., and Yamanishi, K. (1997). Identification of a variant B-specific neutralizing epitope on glycoprotein H of human herpesvirus-6. J. Gen. Virol., 78, 2171–2178.CrossRefGoogle ScholarPubMed
Takeda, K., Haque, M., Nagoshi, E.et al. (2000). Characterization of human herpesvirus 7 U27 gene product and identification of its nuclear localization signal. Virology, 272(2), 394–401.CrossRefGoogle ScholarPubMed
Takemoto, M., Koike, M., Mori, Y., et al. (2005). Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J. Virol., 79(20), 13037–13046.CrossRefGoogle ScholarPubMed
Tanaka, K., Kondo, T., Torigoe, S., Okada, S., Mukai, T., and Yamanishi, K. (1994). Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J. Pediatr., 125, 1–5.CrossRefGoogle Scholar
Tanaka, H., Nishimura, T., Hakui, M., Sugimoto, H., Tanaka-Taya, K., and Yamanishi, K. (2002). Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. Emerg. Infect. Dis., 8(1), 87–88.CrossRefGoogle Scholar
Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M., Killian, J. M., and Zhang, J. Z. (2002). Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol., 76(12), 6147–6154.CrossRefGoogle ScholarPubMed
Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M., and Zhang, J. Z. (2003). Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol., 53(2), 189–197.CrossRefGoogle ScholarPubMed
Tong, C. Y., Bakran, A., Williams, H., Cheung, C. Y., and Peiris, J. S. (2000). Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation, 70(1), 213–216.Google ScholarPubMed
Tong, C. Y., Bakran, A., Peiris, J. S., Muir, P., and Simon, H. C. (2002). The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation, 74(4), 576–578.CrossRefGoogle ScholarPubMed
Torigoe, S., Kumamoto, T., Koide, W., Taya, K., and Yamanishi, K. (1995). Clinical manifestations associated with human herpesvirus 7 infection. Arch. Dis. Child., 72(6), 518–519.CrossRefGoogle ScholarPubMed
Tsukazaki, T., Yoshida, M., Namba, H., Yamada, M., Shimizu, N., and Nii, S. (1998). Development of a dot blot neutralizing assay for HHV-6 and HHV-7 using specific monoclonal antibodies. J. Virol. Methods, 73(2), 141–149.CrossRefGoogle ScholarPubMed
Tyler, K. L. (2003). Human herpesvirus 6 and multiple sclerosis: the continuing conundrum. J. Infect. Dis., 187(9), 1360–1364.CrossRefGoogle ScholarPubMed
Wagner, J. A., Ross, H., Gamberg, P., Valantine, H., Merigan, T. C., and Stinson, E. B. (1995). Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. Transplantation, 60, 1473–1477.CrossRefGoogle ScholarPubMed
Wang, F. Z., Dahl, H., Linde, A., Brytting, M., Ehrnst, A., and Ljungman, P. (1996). Lymphotropic herpesviruses in allogenic bone marrow transplantation. Blood, 88, 3615–3620.Google Scholar
Wang, F. Z., Linde, A., Dahl, H., and Ljungman, P. (1999). Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transpl., 24(11), 1201–1206.CrossRefGoogle ScholarPubMed
Ward, K. N., Gray, J. J., Fotheringham, M. W., and Sheldon, M. J. (1993). IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J. Med. Virol., 39, 131–138.CrossRefGoogle ScholarPubMed
Ward, K. N., Turner, D. J., Parada, X. C., and Thiruchelvam, A. D. (2001). Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections. J. Clin. Microbiol., 39(3), 959–963.CrossRefGoogle ScholarPubMed
Ward, K. N., Couto, P. X., Passas, J., and Thiruchelvam, A. D. (2002). Evaluation of the specificity and sensitivity of indirect immunofluorescence tests for IgG to human herpesviruses-6 and -7. J. Virol. Methods, 106(1), 107–113.CrossRefGoogle ScholarPubMed
Wilborn, F., Brinkmann, V., Schmidt, C. A., Neipel, F., Gelderblom, H., and Siegert, W. (1994). Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood, 83(10), 3052–3058.Google ScholarPubMed
Wong, G. A. and Shear, N. H. (2004). Is a drug alone sufficient to cause the drug hypersensitivity syndrome?Arch. Dermatol., 140(2), 226–230.CrossRefGoogle ScholarPubMed
Wu, C. A. and Shanley, J. D. (1998). Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J. Gen. Virol., 79, 1247–1256.CrossRefGoogle ScholarPubMed
Wyatt, L. S. and Frenkel, N. (1992). Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J. Virol., 66(5), 3206–3209.Google ScholarPubMed
Wyatt, L. S., Balachandran, N., and Frenkel, N. (1990). Variations in the replication and antigenic properties of human herpesvirus 6 strains. J. Infect. Dis., 162(4), 852–857.CrossRefGoogle ScholarPubMed
Wyatt, L. S., Rodriguez, W. J., Balachandran, N., and Frenkel, N. (1991). Human herpesvirus 7: antigenic properties and prevalence in children and adults. J. Virol., 65, 6260–6265.Google ScholarPubMed
Yadav, M.Umamaheswari, S., and Ablashi, D. (1991). Antibody reactivity with two strains of human herpesvirus-6 in Malaysians. J. Med. Virol., 33, 236–239.CrossRefGoogle ScholarPubMed
Yakushijin, Y., Yasukawa, M., and Kobayashi, Y. (1991). T-cell immune response to human herpesvirus-6 in healthy adults. Microbiol. Immunol. 35(8), 655–660.CrossRefGoogle ScholarPubMed
Yakushijin, Y., Yasukawa, M., and Kobayashi, Y. (1992). Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones. J. Virol., 66(5), 2773–2779.Google ScholarPubMed
Yamamoto, M., Black, J. B., Stewart, J. A., Lopez, C., and Pellett, P. E. (1990). Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J. Clin. Microbiol., 28(9), 1957–1962.Google ScholarPubMed
Yamanishi, K., Mori, Y., and Pellett, P. E. (2007). Human herpesviruses 6 and 7. In Fields Virology, 5th edn., Knipe, et al., eds., Philadelphia: Lippincott, Williams, & Wilkins, Vol. 2, Chap. 71, in press.Google Scholar
Yasukawa, M., Yakushijin, Y., Furukawa, M., and Fujita, S. (1993). Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol., 67(10), 6259–6264.Google Scholar
Yasukawa, M., Inoue, Y., Ohminami, H., Terada, K., and Fujita, S. (1998). Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J. Gen. Virol., 79, 143–147.CrossRefGoogle ScholarPubMed
Yasukawa, M., Hasegawa, A., Sakai, I.et al. (1999). Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J. Immunol., 162(9), 5417–5422.Google ScholarPubMed
Yoshida, M., Torigoe, S., Ikeue, K., and Yamada, M. (2002a). Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal neutralizing antibodies contribute to sequential infection with these viruses in childhood. Clin. Diagn. Lab. Immunol., 9(2), 388–393.Google Scholar
Yoshida, M., Torigoe, S., and Yamada, M. (2002b). Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies. Clin. Diagn. Lab. Immunol., 9(2), 394–402.Google Scholar
Yoshikawa, T. (2003). Human herpesvirus-6 and -7 infections in transplantation. Pediatr. Transpl., 7(1), 11–17.CrossRefGoogle ScholarPubMed
Yoshikawa, T., Suga, S., Asano, Y.et al. (1991). Human herpesvirus-6 infection in bone marrow transplantation. Blood, 78, 1381–1384.Google ScholarPubMed
Yoshikawa, T., Ihira, M., Suzuki, K.et al. (2000). Human herpesvirus 6 infection after living related liver transplantation. J. Med. Virol., 62, 52–59.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
Yoshikawa, T., Asano, Y., Ihira, M.et al. (2002). Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J. Infect. Dis., 185(7), 847–853.CrossRefGoogle ScholarPubMed
Yoshikawa, T., Goshima, F., Akimoto, S.et al. (2003a). Human herpesvirus 6 infection of human epidermal cell line: pathogenesis of skin manifestations. J. Med. Virol., 71(1), 62–68.CrossRefGoogle Scholar
Yoshikawa, T., Yoshida, J., Hamaguchi, M.et al. (2003b). Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation. J. Med. Virol., 70(3), 440–443.CrossRefGoogle Scholar
Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y., and Yamanishi, K. (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol., 73(7), 5926–5933.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×